Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$864M |
| 2 |
Shopify
SHOP
|
+$624M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$502M |
| 4 |
TSMC
TSM
|
+$470M |
| 5 |
Constellation Energy
CEG
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$843M |
| 3 |
Broadcom
AVGO
|
+$764M |
| 4 |
Amazon
AMZN
|
+$530M |
| 5 |
Uber
UBER
|
+$520M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Communication Services | 17.48% |
| 3 | Consumer Discretionary | 14.75% |
| 4 | Healthcare | 9.68% |
| 5 | Financials | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GDEN
351
DELISTED
Golden Entertainment
GDEN
| $16M | 0.01% |
543,982
+21,415
| +4% | +$584K |
|
352
Republic Services
RSG
$65.1B
| $15.7M | 0.01% |
63,754
+2,586
| +4% | +$639K |
|
353
Cogent Communications
CCOI
$677M
| $15.6M | 0.01% |
323,511
+24,495
| +8% | +$1.24M |
|
|
CFLT
354
DELISTED
Confluent
CFLT
| $15.4M | 0.01% |
616,030
-3,462
| -0.6% | -$78K |
|
355
Ferrovial N.V. Ordinary Shares
FER
$47.2B
| $15.1M | 0.01% |
285,804
-59,702
| -17% | -$2.91M |
|
356
Casey's General Stores
CASY
$31.5B
| $14.9M | 0.01% |
+29,175
| New | +$13.4M |
|
|
SOBO
357
South Bow Corp
SOBO
$7.56B
| $14.6M | 0.01% |
563,522
-405,910
| -42% | -$10.3M |
|
358
Freshpet
FRPT
$2.95B
| $14.5M | 0.01% |
213,439
-284,548
| -57% | -$22.2M |
|
359
RadNet
RDNT
$5.3B
| $14.3M | 0.01% |
251,763
+109,656
| +77% | +$6.02M |
|
360
MasTec
MTZ
$20.6B
| $13.9M | 0.01% |
81,830
+8,158
| +11% | +$1.18M |
|
361
Credo Technology Group
CRDO
$36.9B
| $13.9M | 0.01% |
150,138
-473,665
| -76% | -$27.6M |
|
362
Diamondback Energy
FANG
$55.5B
| $13.6M | 0.01% |
99,184
-63,079
| -39% | -$8.74M |
|
|
SION
363
Sionna Therapeutics
SION
$2.09B
| $13.1M | 0.01% |
752,800
-107,127
| -12% | -$1.4M |
|
364
Scholar Rock
SRRK
$5.56B
| $13M | 0.01% |
+365,946
| New | +$11.5M |
|
365
Stantec
STN
$8.23B
| $12.5M | 0.01% |
115,135
+6,143
| +6% | +$591K |
|
|
TTAN
366
ServiceTitan Inc
TTAN
$8.36B
| $12.3M | 0.01% |
+114,617
| New | +$12.8M |
|
367
NeoGenomics
NEO
$2.04B
| $12.2M | 0.01% |
1,663,905
+136,638
| +9% | +$1.1M |
|
368
Descartes Systems
DSGX
$6.73B
| $11.8M | 0.01% |
116,415
-7,507
| -6% | -$792K |
|
369
Apogee Therapeutics
APGE
$10.1B
| $11.7M | 0.01% |
270,366
-23,391
| -8% | -$890K |
|
370
Travere Therapeutics
TVTX
$5.07B
| $11.4M | 0.01% |
771,522
-80,602
| -9% | -$1.34M |
|
371
Intel
INTC
$437B
| $11.3M | 0.01% |
+502,856
| New | +$10.4M |
|
|
PCG.PRX
372
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.37B
| $10.5M | 0.01% |
279,165
| – | – |
|
373
ICICI Bank
IBN
$108B
| $10.1M | 0.01% |
+300,927
| New | +$9.96M |
|
374
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
| $9.99M | 0.01% |
163,883
+119,854
| +272% | +$6.92M |
|
375
First Advantage
FA
$3.53B
| $9.75M | 0.01% |
586,865
+156,577
| +36% | +$2.53M |
|
Similar funds
Jennison Associates's Q2 2025 Portfolio in Review
As of Q2 2025, Jennison Associates held 642 positions worth $169B, up 18% from $143B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Jennison Associates's Q2 2025 filing shows 75 new, 257 increased, 235 reduced and 68 closed positions. Its largest new stake was Thermo Fisher Scientific: 165,992 shares worth $67.3M. The largest sale was Netflix, an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Jennison Associates's largest Q2 2025 buy was Thermo Fisher Scientific: 165,992 shares worth $67.3M.
- Jennison Associates added most to Microsoft in Q2 2025, an estimated $864M increase.
- Jennison Associates's biggest Q2 2025 reduction was Netflix, cutting an estimated $1.03B.
- Jennison Associates fully exited Vertiv in Q2 2025, selling an estimated $308M.
- Jennison Associates's ten largest holdings make up 45% of its $169B portfolio in Q2 2025.
- Jennison Associates opened 75 new positions and closed 68 in Q2 2025.
- Jennison Associates's portfolio value rose 18% quarter-over-quarter to $169B.
Based on Jennison Associates's 13F filing for Q2 2025, filed 1 Aug 2025.